We aimed to stratify clinical risk among patients with high‐volume metastatic hormone‐sensitive prostate cancer (mHSPC) treated with first‐line androgen receptor pathway inhibitor (ARPI) plus androgen deprivation therapy (ADT).
Keiichiro Miyajima, T. Yanagisawa, Wataru Fukuokaya et al.· International journal of uro...· 0 citations
PURPOSE
Variability in routine hematoxylin and eosin (H&E) images is an emerging concern in diagnostic and computational pathology. Although staining variability has been extensively studied, histological section thickness remains a largely unmeasured physical property that may influence image appearance. We investigat...
GG at the PSM independently predicts BCR, with the strongest effect in lower-grade tumors (ISUP 1-2; HR 7.08 for GG4), attenuated in high-grade disease (HR 2.98).
Mehdi Kardoust Parizi, A. Matsukawa, Ichiro Tsuboi et al.· Clinical Genitourinary Cance...· 0 citations
To evaluate perioperative safety, pathological outcomes, and oncological outcomes of en bloc resection of bladder tumor (ERBT) in a large multicenter real‐world cohort.
T. Yanagisawa, A. Matsukawa, K. Iwatani et al.· International journal of uro...· 0 citations
Available evidence does not support a strong or consistent association between dietary factors and bladder cancer (BC) risk, and patients should be informed that dietary modifications alone are unlikely to meaningfully alter their BC risk.
Keiichiro Miyajima, Marcin Miszczyk, Navid Roessler et al.· BJU International· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.